Your browser doesn't support javascript.
loading
Therapeutic Drug Monitoring is More Cost-Effective than a Clinically Based Approach in the Management of Loss of Response to Infliximab in Inflammatory Bowel Disease: An Observational Multicentre Study.
Guidi, Luisa; Pugliese, Daniela; Panici Tonucci, Tommaso; Berrino, Alexandra; Tolusso, Barbara; Basile, Michele; Cantoro, Laura; Balestrieri, Paola; Civitelli, Fortunata; Bertani, Lorenzo; Marzo, Manuela; Felice, Carla; Gremese, Elisa; Costa, Francesco; Viola, Franca; Cicala, Michele; Kohn, Anna; Gasbarrini, Antonio; Rapaccini, Gian Lodovico; Ruggeri, Matteo; Armuzzi, Alessandro.
Afiliação
  • Guidi L; OU Internal Medicine and Gastroenterology Columbus, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • Pugliese D; OU Internal Medicine and Gastroenterology Columbus, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • Panici Tonucci T; OU Internal Medicine and Gastroenterology Columbus, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • Berrino A; Postgraduate School of Health Economics and Management [Altems], Catholic University of the Sacred Heart, Rome, Italy.
  • Tolusso B; OU Rheumatology Columbus, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • Basile M; Postgraduate School of Health Economics and Management [Altems], Catholic University of the Sacred Heart, Rome, Italy.
  • Cantoro L; IBD Unit, Azienda Ospedaliera San Camillo Forlanini, Rome, Italy.
  • Balestrieri P; OU Gastroenterology, Campus Biomedico University, Rome, Italy.
  • Civitelli F; OU Pediatric Gastroenterology, La Sapienza University, Rome, Italy.
  • Bertani L; OU University Gastroenterology, AOU Pisana, Pisa, Italy.
  • Marzo M; OU Internal Medicine and Gastroenterology Columbus, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • Felice C; OU Internal Medicine and Gastroenterology Columbus, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • Gremese E; OU Rheumatology Columbus, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • Costa F; OU University Gastroenterology, AOU Pisana, Pisa, Italy.
  • Viola F; OU Pediatric Gastroenterology, La Sapienza University, Rome, Italy.
  • Cicala M; OU Gastroenterology, Campus Biomedico University, Rome, Italy.
  • Kohn A; IBD Unit, Azienda Ospedaliera San Camillo Forlanini, Rome, Italy.
  • Gasbarrini A; OU Internal Medicine and Gastroenterology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • Rapaccini GL; OU Internal Medicine and Gastroenterology Columbus, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • Ruggeri M; Postgraduate School of Health Economics and Management [Altems], Catholic University of the Sacred Heart, Rome, Italy.
  • Armuzzi A; OU Internal Medicine and Gastroenterology Columbus, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
J Crohns Colitis ; 12(9): 1079-1088, 2018 08 29.
Article em En | MEDLINE | ID: mdl-29860436
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fármacos Gastrointestinais / Doenças Inflamatórias Intestinais / Monitoramento de Medicamentos / Infliximab Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fármacos Gastrointestinais / Doenças Inflamatórias Intestinais / Monitoramento de Medicamentos / Infliximab Idioma: En Ano de publicação: 2018 Tipo de documento: Article